Stryker has entered into a definitive agreement to acquire 100% of the issued and outstanding stake in spine solutions maker K2M Group in an all-cash deal valued at about $1.4bn.

Founded in 2004, K2M Group focuses on developing complex and minimally invasive spine technologies and techniques designed to achieve three-dimensional Total Body Balance.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The K2M portfolio will complement Stryker’s spine business while also providing support with an established footprint in the complex spine market.

“Subject to customary closing conditions and approvals, the acquisition is set to be completed in the fourth quarter of this year.”

Stryker expects the acquired business to bolster its Spine offerings in the core spinal segment and expand its additive manufacturing capabilities.

Stryker chairman and CEO Kevin Lobo said: “This acquisition underscores our commitment to the spinal market, which is the largest segment of Orthopaedics with significant unmet needs.

“We believe K2M will significantly enhance our presence with surgeons, patients and employees in both the spine and related neurotechnology markets.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Subject to customary closing conditions and approvals, the acquisition is set to be completed in the fourth quarter of this year.

After closing of the deal, K2M will become a wholly-owned subsidiary of Stryker. Furthermore, K2M Group chairman, CEO and president Eric Major is expected to be appointed as Stryker Spine division president.

Major said: “Stryker’s established leadership in the orthopaedic and neurosurgical market, combined with K2M’s culture of innovation and leadership in complex spine and minimally invasive solutions, represent a powerful opportunity for Stryker to strengthen its leadership in the $10bn global spine market.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact